Target intelligence / Profile preview

Ellis-van Creveld syndrome protein 2 (EVC2)

Target
EVC2
Molecular classification
Transmembrane protein, Ciliary protein, Signaling protein
01

Overview

Ellis-van Creveld syndrome protein 2 (EVC2) is a transmembrane protein that forms a heterodimeric complex with EVC protein and plays a crucial role in regulating Hedgehog signaling from within primary cilia[1][2]. EVC2 specifically localizes to the EvC zone, a specialized ciliary region located immediately distal to the transition zone of primary cilia[1][3]. The protein is essential for proper skeletal development and chondrogenesis, as mutations in EVC2 cause Ellis-van Creveld syndrome and Weyers acrofacial dysostosis, two rare genetic ciliopathies characterized by chondrodysplastic dwarfism and abnormalities in oral cavity development[1][2]. EVC2 contains a Weyers-deleted peptide (W-peptide) that is critical for proper ciliary targeting through interaction with the EFCAB7-IQCE complex via two essential motifs: the FV motif and the RRKKN motif[1]. The protein undergoes post-translational modifications including ubiquitination and sumoylation that regulate its stability and ciliary localization[1]. EVC2 is expressed in growth plate cartilage, perichondrium, ossified tissues, and muscles, and its dysfunction leads to reduced Hedgehog signaling activity and subsequent skeletal defects[2]. The protein's ciliary localization is mutually dependent on EVC protein, and loss of either component results in failure of the complex to properly localize to cilia and impaired Hedgehog signaling[2].

Other names
LimbinLBNWADEllis van Creveld syndrome 2EvC ciliary complex subunit 2
02

Biological functions

Signal transductionSkeletal developmentCiliary functionHedgehog signaling regulationChondrogenesisOsteogenesis
03

Disease associations

CiliopathySkeletal dysplasiaDevelopmental disorder

Beyond the preview

Go deeper on Ellis-van Creveld syndrome protein 2 (EVC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ellis-van Creveld syndrome protein 2 (EVC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call